Literature DB >> 18520342

Congenital toxoplasmosis: specific IgG subclasses in mother/newborn pairs.

Irma Cañedo-Solares1, María de la Luz Galván-Ramírez, Héctor Luna-Pastén, Laura Rocío Rodríguez Pérez, Luz Belinda Ortiz-Alegría, Claudia Patricia Rico-Torres, Marcela Vela-Amieva, Martha Pérez-Andrade, Ricardo Figueroa-Damián, Dolores Correa.   

Abstract

Anti-Toxoplasma gondii antibodies of all IgG subclasses were studied in mother/newborn pairs. IgG1 in the mothers and IgG3 in the newborns were related to offspring clinical problems; IgG2 and IgG3 in the babies were markers of vertical transmission, and IgG4 in mothers or children were associated to clinical problems. IgG subclasses may be markers of congenital infection or clinical outcome.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18520342     DOI： 10.1097/INF.0b013e31816591df

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  9 in total

1.  Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar.

Authors:  Marawan A Abu-Madi; Jerzy M Behnke; Haydee A Dabritz
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

2.  Toxoplasma-SPECIFIC IgG SUBCLASS ANTIBODY RESPONSE IN CEREBROSPINAL FLUID SAMPLES FROM PATIENTS WITH CEREBRAL TOXOPLASMOSIS.

Authors:  Fernanda S Nascimento; Lisandra A Suzuki; Nilson Branco; Regina M B Franco; Paula D Andrade; Sandra C B Costa; Marcelo N Pedro; Cláudio L Rossi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Sep-Oct       Impact factor: 1.846

Review 3.  Toxoplasmosis in Mexico: epidemiological situation in humans and animals.

Authors:  Ivonne Hernández-Cortazar; Karla Y Acosta-Viana; Antonio Ortega-Pacheco; Eugenia del S Guzman-Marin; Armando J Aguilar-Caballero; Matilde Jiménez-Coello
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

4.  Maternal Immune Response During Pregnancy and Vertical Transmission in Human Toxoplasmosis.

Authors:  Fernando Gómez-Chávez; Irma Cañedo-Solares; Luz Belinda Ortiz-Alegría; Yevel Flores-García; Héctor Luna-Pastén; Ricardo Figueroa-Damián; Juan Carlos Mora-González; Dolores Correa
Journal:  Front Immunol       Date:  2019-02-21       Impact factor: 7.561

5.  Testing New Peptides From Toxoplasma gondii SAG1, GRA6, and GRA7 for Serotyping: Better Definition Using GRA6 in Mother/Newborns Pairs With Risk of Congenital Transmission in Mexico.

Authors:  Lizbeth Xicoténcatl-García; Sergio Enriquez-Flores; Dolores Correa
Journal:  Front Cell Infect Microbiol       Date:  2019-10-23       Impact factor: 5.293

6.  Comparative Performance of Recombinant GRA6, GRA7, and GRA14 for the Serodetection of T. gondii Infection and Analysis of IgG Subclasses in Human Sera from the Philippines.

Authors:  Rochelle Haidee Ybañez; Yoshifumi Nishikawa
Journal:  Pathogens       Date:  2022-02-21

7.  Comparative Detection of Immunoglobulin Isotypes and Subclasses against Toxoplasma gondii Soluble Antigen in Serum and Colostrum Samples from Puerperal Women.

Authors:  Hellen Dayane Silva Borges; Ana Carolina Morais Oliveira-Scussel; Ângela Maria Morais Oliveira; Vânia Olivetti Steffen Abdallah; Ana Cláudia Arantes Marquez Pajuaba; José Roberto Mineo
Journal:  Int J Environ Res Public Health       Date:  2022-06-29       Impact factor: 4.614

8.  Association of gestational diabetes mellitus and negative modulation of the specific humoral and cellular immune response against Toxoplasma gondii.

Authors:  Ana Carolina de Morais Oliveira-Scussel; Paula Tatiana Mutão Ferreira; Renata de Souza Resende; Cristhianne Molinero Ratkevicius-Andrade; Angelica de Oliveira Gomes; Marina Carvalho Paschoini; Fernanda Bernadelli De Vito; Thaís Soares Farnesi-de-Assunção; Marcos Vinícius da Silva; José Roberto Mineo; Denise Bertulucci Rocha Rodrigues; Virmondes Rodrigues
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

9.  A Proinflammatory Immune Response Might Determine Toxoplasma gondii Vertical Transmission and Severity of Clinical Features in Congenitally Infected Newborns.

Authors:  Fernando Gómez-Chávez; Irma Cañedo-Solares; Luz Belinda Ortiz-Alegría; Yevel Flores-García; Ricardo Figueroa-Damián; Héctor Luna-Pastén; Valeria Gómez-Toscano; Carlos López-Candiani; G Emmanuel Arce-Estrada; Christian A Bonilla-Ríos; Juan Carlos Mora-González; Ricardo García-Ruiz; Dolores Correa
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.